000			01885nam a2200433 i 4500
999			_c290066 _d290066
001			on1127909170
003			OCoLC
005			20200212134849.0
006			m o d f
007			cr |||||||||||
008			191118s2019 dcu ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dMvI
042			_apcc
043			_an-us---
074			_a1002-C (online)
086	0		_aY 4.T 19/4:D 84
088			_aJCX-43-19
099			_aY 4.T 19/4:D 84
245	0	0	_aDescription of the revenue provisions of H.R. 3, the "Lower Drug Costs Now Act of 2019" : _bscheduled for markup by the House Committee on Ways and Means on October 22, 2019 / _cprepared by the staff of the Joint Committee on Taxation.
246	3	0	_aH.R. 3, the "Lower Drug Costs Now Act of 2019"
264		1	_a[Washington, D.C.] : _b[Joint Committee on Taxation], _c[2019]
300			_a1 online resource (i, 9 pages )
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
500			_a"October 18, 2019."
500			_a"JCX-43-19."
500			_aGPO Cataloging Record Distribution Program (CRDP).
504			_aIncludes bibliographical references.
588			_aDescription based on online resource; title from PDF cover (Govinfo website, viewed Nov. 18, 2019).
710	1		_aUnited States. _bCongress. _bJoint Committee on Taxation,
710	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Ways and Means.
776	0	8	_iPrint version: _tDescription of the revenue provisions of H.R. 3, the "Lower Drug Costs Now Act of 2019" _w(OCoLC)1124761100
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo128577
650		0	_aPrescription pricing _xGovernment policy _zUnited States.
650		0	_aPharmaceutical industry _xGovernment policy _zUnited States.
650		0	_aDrugs _zUnited States _xCost control.
942			_2sudocs _c8